Bar Harbor Wealth Management lifted its position in Ryan Specialty Holdings, Inc. (NYSE:RYAN - Free Report) by 4.9% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 177,097 shares of the company's stock after acquiring an additional 8,226 shares during the quarter. Bar Harbor Wealth Management owned approximately 0.07% of Ryan Specialty worth $13,082,000 at the end of the most recent reporting period.
Other institutional investors have also recently made changes to their positions in the company. Mutual of America Capital Management LLC grew its stake in shares of Ryan Specialty by 1.7% in the 4th quarter. Mutual of America Capital Management LLC now owns 56,203 shares of the company's stock worth $3,606,000 after acquiring an additional 914 shares in the last quarter. Truist Financial Corp grew its position in Ryan Specialty by 7.2% during the fourth quarter. Truist Financial Corp now owns 5,688 shares of the company's stock valued at $365,000 after buying an additional 381 shares during the period. Stephens Inc. AR grew its position in Ryan Specialty by 33.9% during the fourth quarter. Stephens Inc. AR now owns 5,836 shares of the company's stock valued at $374,000 after buying an additional 1,477 shares during the period. CIBC Private Wealth Group LLC grew its position in Ryan Specialty by 6,911.0% during the fourth quarter. CIBC Private Wealth Group LLC now owns 785,928 shares of the company's stock valued at $48,036,000 after buying an additional 774,718 shares during the period. Finally, Sanctuary Advisors LLC grew its position in Ryan Specialty by 1.2% during the fourth quarter. Sanctuary Advisors LLC now owns 15,690 shares of the company's stock valued at $1,045,000 after buying an additional 188 shares during the period. Institutional investors own 84.82% of the company's stock.
Ryan Specialty Price Performance
Shares of Ryan Specialty stock traded down $0.40 on Friday, reaching $65.85. The stock had a trading volume of 859,058 shares, compared to its average volume of 993,351. Ryan Specialty Holdings, Inc. has a 1 year low of $52.34 and a 1 year high of $77.16. The company has a market cap of $17.28 billion, a P/E ratio of 95.44, a price-to-earnings-growth ratio of 1.19 and a beta of 0.70. The company has a current ratio of 1.01, a quick ratio of 1.01 and a debt-to-equity ratio of 2.40. The business's 50 day moving average is $69.08 and its two-hundred day moving average is $68.54.
Ryan Specialty (NYSE:RYAN - Get Free Report) last announced its quarterly earnings results on Thursday, May 1st. The company reported $0.39 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.39. Ryan Specialty had a net margin of 9.14% and a return on equity of 48.01%. The firm had revenue of $690.17 million for the quarter, compared to the consensus estimate of $680.80 million. During the same period in the prior year, the firm posted $0.35 earnings per share. The company's revenue for the quarter was up 25.0% on a year-over-year basis. As a group, research analysts anticipate that Ryan Specialty Holdings, Inc. will post 2.29 EPS for the current year.
Ryan Specialty Dividend Announcement
The company also recently declared a quarterly dividend, which was paid on Tuesday, May 27th. Stockholders of record on Tuesday, May 13th were issued a $0.12 dividend. This represents a $0.48 dividend on an annualized basis and a dividend yield of 0.73%. The ex-dividend date was Tuesday, May 13th. Ryan Specialty's payout ratio is 141.18%.
Wall Street Analysts Forecast Growth
Several research firms recently weighed in on RYAN. The Goldman Sachs Group upgraded shares of Ryan Specialty from a "neutral" rating to a "buy" rating and increased their price target for the company from $74.00 to $81.00 in a research report on Tuesday, May 13th. Keefe, Bruyette & Woods reduced their price target on shares of Ryan Specialty from $76.00 to $75.00 and set an "outperform" rating for the company in a research report on Wednesday, April 9th. TD Cowen began coverage on shares of Ryan Specialty in a research report on Thursday, April 10th. They set a "buy" rating and a $89.00 price target for the company. Morgan Stanley increased their target price on shares of Ryan Specialty from $78.00 to $80.00 and gave the stock an "overweight" rating in a research report on Monday, May 19th. Finally, Barclays cut their target price on shares of Ryan Specialty from $88.00 to $83.00 and set an "overweight" rating for the company in a research report on Friday, April 11th. One research analyst has rated the stock with a sell rating, three have given a hold rating and eight have assigned a buy rating to the stock. According to MarketBeat, the company has a consensus rating of "Moderate Buy" and a consensus target price of $75.58.
View Our Latest Report on RYAN
Insider Transactions at Ryan Specialty
In related news, Director David P. Bolger sold 5,000 shares of the company's stock in a transaction that occurred on Tuesday, June 3rd. The shares were sold at an average price of $70.80, for a total value of $354,000.00. Following the transaction, the director now directly owns 71,467 shares in the company, valued at approximately $5,059,863.60. This represents a 6.54% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Insiders own 52.21% of the company's stock.
Ryan Specialty Company Profile
(
Free Report)
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Recommended Stories

Before you consider Ryan Specialty, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ryan Specialty wasn't on the list.
While Ryan Specialty currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking for the next FAANG stock before everyone has heard about it? Enter your email address to see which stocks MarketBeat analysts think might become the next trillion dollar tech company.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.